Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995-2010

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Rooney, James ^a   Byrne, Susan ^a   Heverin, Mark ^a   Corr, Bernie ^b   Elamin, Marwa ^a   Staines, Anthony ^c   Goldacre, Ben ^d   Hardiman, Orla ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

^c DUBLIN CITY UNIVERSITY   (Ireland)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COMPUTER PROGRAM; DRUG USE; ETHNIC GROUP; FEMALE; HUMAN; IRISH; MAJOR CLINICAL STUDY; MALE; NONPARAMETRIC TEST; PROPORTIONAL HAZARDS MODEL; ROYSTON PARMAR FLEXIBLE PARAMETRIC MODELING; STATISTICAL MODEL; SURVIVAL;

AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IRELAND; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84884809148     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074733     Document Type: Article

References (24)

1. Hardiman O, van den Berg LH, Kiernan MC (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nature reviews Neurology 7: 639-649. PMID: 21989247.
2. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, et al. (1999) Incidence and prevalence of ALS in Ireland, 1995-1997: A population-based study. Neurology 52: 504-504. PMID: 10025778.
3. Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, et al. (2009) Prognostic factors in ALS: A critical review. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 10: 310-323. PMID: 19922118.
4. Elamin M, Phukan J, Bede P, Jordan N, Byrne S, et al. (2011) Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 76: 1263-1269. PMID: 21464431.
5. Miller RG, Mitchell JD, Moore DH (2012) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane database of systematic reviews (Online) 3: CD001447. PMID: 22419278.
6. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O (2003) Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. Journal of neurology, neurosurgery, and psychiatry 74: 1258-1261. PMID: 12933930.
7. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, et al. (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet neurology 5: 140-147. PMID: 16426990.
8. Cox DR, (1972) Regression Models and Life-Tables. Journal of the Royal Statistical Society Series B (Methodological) 34: 187-220.
9. Royston P, Lambert PC, (2011) Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model. Frist Edit. Stata Press. ISBN-13: 978-1-59718-079-5.
10. Cleves M, Gould W, Gutierrez R, Marchenko Y, (2010) An Introduction to Survival Analysis Using Stata, Third Edition. Third Edit. Stata Press. ISBN-13: 978-1-59718-074-0.
11. StataCorp LP, (2009) STATA SURVIVAL ANALYSIS AND EPIDEMIOLOGICAL TABLES REFERENCEMANUAL RELEASE 11. Stata Press. ISBN-13: 978-1-59718-061-0.
12. Royston P, Parmar MKB (2002) Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Statistics in medicine 21: 2175-2197. PMID: 12210632.
13. Aboussouan LS, Khan SU, Banerjee M, Arroliga AC, Mitsumoto H (2001) Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle & nerve 24: 403-409. PMID: 11353427.
14. Paillisse C, Lacomblez L, Dib M, Bensimon G, Garcia-Acosta S, et al. (2005) Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 6: 37-44. PMID: 16036424.
15. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, et al. (2000) Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. Archives of neurology 57: 1171-1176. PMID: 10927797.
16. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, et al. (2008) Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. Journal of the neurological sciences 268: 28-32. PMID: 18021808.
17. Chiò A, Mora G, Leone M, Mazzini L, Cocito D, et al. (2002) Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 59: 99-103. PMID: 12105314.
18. Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. American journal of epidemiology 145: 72-80. PMID: 9290515.
19. Thiébaut ACM, Bénichou J (2004) Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Statistics in medicine 23: 3803-3820. PMID: 15580597.
20. Cheung YB, Gao F, Khoo KS (2003) Age at diagnosis and the choice of survival analysis methods in cancer epidemiology. Journal of clinical epidemiology 56: 38-43. PMID: 12589868.
21. StataCorp. 2009. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP.
22. Lambert P (2012) STPM2: Stata module to estimate flexible parametric survival models. BIOSENSORS & BIOELECTRONICS 37: 11-18. Available: http://ideas.repec.org/c/boc/bocode/s457128.html Accessed December 2012.
23. Katz MH (2011) Multivariable Analysis. A Practical Guide for Clinicians and Public Health Researchers. Third Edit. Cambridge.
24. Sun GW, Shook TL, Kay GL (1996) Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. Journal of clinical epidemiology 49: 907-916. PMID: 8699212.